1. Home
  2. KRYS vs SPXC Comparison

KRYS vs SPXC Comparison

Compare KRYS & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$305.25

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

N/A

Current Price

$150.37

Market Cap

9.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KRYS
SPXC
Founded
2015
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.7B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
KRYS
SPXC
Price
$305.25
$150.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
14
Target Price
★ $388.22
$236.77
AVG Volume (30 Days)
296.5K
★ 713.9K
Earning Date
11-02-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 128.00
18.08
EPS
★ 5.66
4.35
Revenue
$389,130,000.00
★ $2,265,100,000.00
Revenue This Year
$27.84
$22.67
Revenue Next Year
$27.62
$15.88
P/E Ratio
$54.71
★ $35.30
Revenue Growth
★ 33.94
14.17
52 Week Low
$198.02
$137.86
52 Week High
$382.54
$251.08

Technical Indicators

Market Signals
Indicator
KRYS
SPXC
Relative Strength Index (RSI) 43.87 40.30
Support Level $284.16 $137.86
Resistance Level $317.53 $180.49
Average True Range (ATR) 11.47 7.27
MACD 0.01 -0.17
Stochastic Oscillator 49.77 43.03

Price Performance

Historical Comparison
KRYS
SPXC

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: